Susan L. Garson

2.3k total citations
19 papers, 850 citations indexed

About

Susan L. Garson is a scholar working on Cognitive Neuroscience, Endocrine and Autonomic Systems and Experimental and Cognitive Psychology. According to data from OpenAlex, Susan L. Garson has authored 19 papers receiving a total of 850 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cognitive Neuroscience, 15 papers in Endocrine and Autonomic Systems and 14 papers in Experimental and Cognitive Psychology. Recurrent topics in Susan L. Garson's work include Sleep and Wakefulness Research (16 papers), Sleep and related disorders (14 papers) and Circadian rhythm and melatonin (14 papers). Susan L. Garson is often cited by papers focused on Sleep and Wakefulness Research (16 papers), Sleep and related disorders (14 papers) and Circadian rhythm and melatonin (14 papers). Susan L. Garson collaborates with scholars based in United States, Japan and China. Susan L. Garson's co-authors include John J. Renger, Anthony L. Gotter, Christopher J. Winrow, Paul J. Coleman, Steven V. Fox, Pamela L. Tannenbaum, Joanne Stevens, C. Meacham Harrell, Duane R. Reiss and Scott M. Doran and has published in prestigious journals such as Journal of Clinical Investigation, Scientific Reports and Neuropsychopharmacology.

In The Last Decade

Susan L. Garson

19 papers receiving 828 citations

Peers

Countries citing papers authored by Susan L. Garson

Since Specialization

Citations

This map shows the geographic impact of Susan L. Garson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan L. Garson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan L. Garson more than expected).

Fields of papers citing papers by Susan L. Garson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan L. Garson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan L. Garson. The network helps show where Susan L. Garson may publish in the future.

Co-authorship network of co-authors of Susan L. Garson

This figure shows the co-authorship network connecting the top 25 collaborators of Susan L. Garson. A scholar is included among the top collaborators of Susan L. Garson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan L. Garson. Susan L. Garson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Orexin 2 Receptor Antagonism is Sufficient to Promote NREM and REM Sleep from Mouse to Man 2016 ·Scientific Reports ·Anthony L. Gotter, Mark S. Forman, C. Meacham Harrell, Joanne Stevens, Vladimir Svetnik, Ka Lai Yee, Xiaodong Li, Anthony J. Roecker, Steven V. Fox, Pamela L. Tannenbaum, Susan L. Garson, Inge De Lepeleire, Nicole Calder, Laura Rosen, Arie Struyk, Paul J. Coleman, W. Joseph Herring, John J. Renger, Christopher J. Winrow	67
2	Discovery of diazepane amide DORAs and 2-SORAs enabled by exploration of isosteric quinazoline replacements 2015 ·Bioorganic & Medicinal Chemistry Letters ·Anthony J. Roecker, Swati P. Mercer, Jeffrey M. Bergman, Kevin F. Gilbert, Scott D. Kuduk, C. Meacham Harrell, Susan L. Garson, Steven V. Fox, Anthony L. Gotter, Pamela L. Tannenbaum, Thomayant Prueksaritanont, Tamara D. Cabalu, Donghui Cui, Wei Lemaire, Christopher J. Winrow, John J. Renger, Paul J. Coleman	14
3	Identification of MK-8133: An orexin-2 selective receptor antagonist with favorable development properties 2015 ·Bioorganic & Medicinal Chemistry Letters ·Scott D. Kuduk, (unknown), (unknown), Joseph G. Bruno, Mark H. Pausch, Julie A. O’Brien, Tamara D. Cabalu, Joanne Stevens, (unknown), Pamela L. Tannenbaum, Susan L. Garson, Alan T. Savitz, C. Meacham Harrell, Anthony L. Gotter, Christopher J. Winrow, John J. Renger, Paul J. Coleman	15
4	Differential sleep-promoting effects of dual orexin receptor antagonists and GABAAreceptor modulators 2014 ·BMC Neuroscience ·Anthony L. Gotter, Susan L. Garson, Joanne Stevens, (unknown), Steven V. Fox, Pamela L. Tannenbaum, Lihang Yao, Scott D. Kuduk, Terrence McDonald, Jason M. Uslaner, Spencer J. Tye, Paul J. Coleman, Christopher J. Winrow, John J. Renger	40
5	Orexin receptor antagonist-induced sleep does not impair the ability to wake in response to emotionally salient acoustic stimuli in dogs 2014 ·Frontiers in Behavioral Neuroscience ·Pamela L. Tannenbaum, Joanne Stevens, (unknown), Alan T. Savitz, Susan L. Garson, Steven V. Fox, Paul J. Coleman, Scott D. Kuduk, Anthony L. Gotter, Michael J. Marino, Spencer J. Tye, Jason M. Uslaner, Christopher J. Winrow, John J. Renger	32
6	Discovery of dual orexin receptor antagonists with rat sleep efficacy enabled by expansion of the acetonitrile-assisted/diphosgene-mediated 2,4-dichloropyrimidine synthesis 2014 ·Bioorganic & Medicinal Chemistry Letters ·Anthony J. Roecker, Swati P. Mercer, C. Meacham Harrell, Susan L. Garson, Steven V. Fox, Anthony L. Gotter, Thomayant Prueksaritanont, Tamara D. Cabalu, Donghui Cui, Wei Lemaire, Christopher J. Winrow, John J. Renger, Paul J. Coleman	9
7	Discovery of piperidine ethers as selective orexin receptor antagonists (SORAs) inspired by filorexant 2014 ·Bioorganic & Medicinal Chemistry Letters ·Izzat T. Raheem, Michael J. Breslin, Joseph G. Bruno, Tamara D. Cabalu, Andrew Cooke, Christopher D. Cox, Donghui Cui, Susan L. Garson, Anthony L. Gotter, Steven V. Fox, C. Meacham Harrell, Scott D. Kuduk, Wei Lemaire, Thomayant Prueksaritanont, John J. Renger, Craig A. Stump, Pamela L. Tannenbaum, Peter D. Williams, Christopher J. Winrow, Paul J. Coleman	17
8	Quantitative Electroencephalography Within Sleep/Wake States Differentiates GABAA Modulators Eszopiclone and Zolpidem From Dual Orexin Receptor Antagonists in Rats 2013 ·Neuropsychopharmacology ·Steven V. Fox, Anthony L. Gotter, Spencer J. Tye, Susan L. Garson, Alan T. Savitz, Jason M. Uslaner, (unknown), Pamela L. Tannenbaum, Terrence P. McDonald, Robert A. Hodgson, Lihang Yao, Mark R. Bowlby, Scott D. Kuduk, Paul J. Coleman, Richard Hargreaves, Christopher J. Winrow, John J. Renger	33
9	The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy threshold 2013 ·BMC Neuroscience ·Anthony L. Gotter, Christopher J. Winrow, (unknown), Susan L. Garson, Steven V. Fox, (unknown), C. Meacham Harrell, Donghui Cui, Ka Lai Yee, (unknown), Joanne Stevens, Alan T. Savitz, Pamela L. Tannenbaum, Spencer J. Tye, Terrence P. McDonald, (unknown), Scott D. Kuduk, Jason M. Uslaner, Paul J. Coleman, John J. Renger	76
10	Dual orexin receptor antagonists show distinct effects on locomotor performance, ethanol interaction and sleep architecture relative to gamma-aminobutyric acid-A receptor modulators 2013 ·Frontiers in Neuroscience ·Andres D. Ramirez, Anthony L. Gotter, Steven V. Fox, Pamela L. Tannenbaum, Lihang Yao, Spencer J. Tye, Terrence P. McDonald, (unknown), Susan L. Garson, Duane R. Reiss, Scott D. Kuduk, Paul J. Coleman, Jason M. Uslaner, Robert A. Hodgson, Susan Browne, John J. Renger, Christopher J. Winrow	33
11	Discovery of 2,5-diarylnicotinamides as selective orexin-2 receptor antagonists (2-SORAs) 2013 ·Bioorganic & Medicinal Chemistry Letters ·Swati P. Mercer, Anthony J. Roecker, Susan L. Garson, Duane R. Reiss, C. Meacham Harrell, Kathy Murphy, Joseph G. Bruno, Rodney A. Bednar, Wei Lemaire, Donghui Cui, Tamara D. Cabalu, Cuyue Tang, Thomayant Prueksaritanont, George D. Hartman, Steven D. Young, Christopher J. Winrow, John J. Renger, Paul J. Coleman	19
12	Pharmacological characterization of MK-6096 – A dual orexin receptor antagonist for insomnia 2011 ·Neuropharmacology ·Christopher J. Winrow, Anthony L. Gotter, Christopher D. Cox, Pamela L. Tannenbaum, Susan L. Garson, Scott M. Doran, Michael J. Breslin, John D. Schreier, Steven V. Fox, C. Meacham Harrell, Joanne Stevens, Duane R. Reiss, Donghui Cui, Paul J. Coleman, John J. Renger	109
13	Pharmacological Validation of Candidate Causal Sleep Genes Identified in an N2 Cross 2011 ·Journal of Neurogenetics ·(unknown), Anthony L. Gotter, Joshua Millstein, Susan L. Garson, (unknown), Steven V. Fox, Alan T. Savitz, He S. Yang, (unknown), (unknown), (unknown), Andrea L. Webber, Martha Hotz Vitaterna, Andrew Kasarskis, Victor N. Uebele, Fred W. Turek, John J. Renger, Christopher J. Winrow	7
14	Promotion of Sleep by Suvorexant—A Novel Dual Orexin Receptor Antagonist 2011 ·Journal of Neurogenetics ·Christopher J. Winrow, Anthony L. Gotter, Christopher D. Cox, Scott M. Doran, Pamela L. Tannenbaum, Michael J. Breslin, Susan L. Garson, Steven V. Fox, C. Meacham Harrell, Joanne Stevens, Duane R. Reiss, Donghui Cui, Paul J. Coleman, John J. Renger	218
15	Discovery of 3,9-diazabicyclo[4.2.1]nonanes as potent dual orexin receptor antagonists with sleep-promoting activity in the rat 2010 ·Bioorganic & Medicinal Chemistry Letters ·Paul J. Coleman, John D. Schreier, Anthony J. Roecker, Swati P. Mercer, Georgia B. McGaughey, Christopher D. Cox, George D. Hartman, C. Meacham Harrell, Duane R. Reiss, Scott M. Doran, Susan L. Garson, Wayne B. Anderson, Cuyue Tang, Thomayant Prueksaritanont, Christopher J. Winrow, John J. Renger	21
16	Antagonism of T-type calcium channels inhibits high-fat diet–induced weight gain in mice 2009 ·Journal of Clinical Investigation ·Victor N. Uebele, Anthony L. Gotter, Cindy E. Nuss, Richard L. Kraus, Scott M. Doran, Susan L. Garson, Duane R. Reiss, Yuxing Li, James C. Barrow, Thomas S. Reger, Zhi-Qiang Yang, Jeanine Ballard, Cuyue Tang, Joseph M. Metzger, (unknown), Kenneth S. Koblan, John J. Renger	61
17	Orexin receptor antagonism prevents transcriptional and behavioral plasticity resulting from stimulant exposure 2009 ·Neuropharmacology ·Christopher J. Winrow, Keith Q. Tanis, Duane R. Reiss, Alison Rigby, Jason M. Uslaner, Victor N. Uebele, Scott M. Doran, Steven V. Fox, Susan L. Garson, Anthony L. Gotter, David Levine, Anthony J. Roecker, Paul J. Coleman, Kenneth S. Koblan, John J. Renger	61
18	T-type calcium channels regulate cortical plasticity in-vivo NR-D-08-7049 2009 ·Neuroreport ·Victor N. Uebele, Cindy E. Nuss, Vincent P. Santarelli, Susan L. Garson, James C. Barrow, Shaun R. Stauffer, Kenneth S. Koblan, John J. Renger, Sara J. Aton, Julie Seibt, Michelle Dumoulin, Sushil K. Jha, Tammi Coleman, Marcos G. Frank	15
19	P4‐332: In vivo pharmacodynamic effects of BQCA, a novel selective allosteric M1 receptor modulator 2008 ·Alzheimer s & Dementia ·Marion Wittmann, Guangping Xu, Michelle Pearson, Susan L. Garson, Scott M. Doran, John J. Renger, Andrew Danziger, Christopher P. Regan, Guy R. Seabrook, William J. Ray	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact